| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis (NCT04341454) | Daewoong Pharmaceutical Co. LTD. | 2020-06-02 |
| Effects of Food on the Pharmacokinetics of DWJ1458 in Healthy Adults (NCT04393597) | Daewoong Pharmaceutical Co. LTD. | 2020-05-28 |
| Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults (NCT04343547) | Daewoong Pharmaceutical Co. LTD. | 2020-04-01 |
| Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy (NCT04294251) | Daewoong Pharmaceutical Co. LTD. | 2020-03-04 |
| Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate (NCT05083299) | Daewoong Pharmaceutical Co. LTD. | 2020-01-28 |
| Type 2 Diabetes Patients With Renal Impairment (NCT04221399) | Daewoong Pharmaceutical Co. LTD. | 2020-01-01 |
| Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers (NCT04159961) | Daewoong Pharmaceutical Co. LTD. | 2019-12-24 |
| Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III) (NCT04185805) | Daewoong Pharmaceutical Co. LTD. | 2019-12-14 |
| Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab (NCT05184179) | Daewoong Pharmaceutical Co. LTD. | 2019-12-01 |
| Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 (NCT04161001) | Daewoong Pharmaceutical Co. LTD. | 2019-11-20 |
| Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II) (NCT04167267) | Daewoong Pharmaceutical Co. LTD. | 2019-11-01 |
| Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (NCT04120753) | Daewoong Pharmaceutical Co. LTD. | 2019-08-26 |
| Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study) (NCT04064073) | Daewoong Pharmaceutical Co. LTD. | 2019-08-14 |
| Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers (NCT04278391) | Daewoong Pharmaceutical Co. LTD. | 2019-07-02 |
| Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat (NCT03946592) | Daewoong Pharmaceutical Co. LTD. | 2019-05-15 |
| Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions (NCT03947528) | Daewoong Pharmaceutical Co. LTD. | 2019-03-04 |
| Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions (NCT03947489) | Daewoong Pharmaceutical Co. LTD. | 2019-03-04 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease (NCT03811080) | Daewoong Pharmaceutical Co. LTD. | 2019-02-07 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) (NCT03736369) | Daewoong Pharmaceutical Co. LTD. | 2018-12-13 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean (NCT03574415) | Daewoong Pharmaceutical Co. LTD. | 2018-11-01 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions (NCT03574285) | Daewoong Pharmaceutical Co. LTD. | 2018-05-31 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions (NCT03573622) | Daewoong Pharmaceutical Co. LTD. | 2018-05-31 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects (NCT03487562) | Daewoong Pharmaceutical Co. LTD. | 2018-04-08 |
| Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B Patients (NCT03485534) | Daewoong Pharmaceutical Co. LTD. | 2018-01-23 |
| Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 (NCT03753477) | Daewoong Pharmaceutical Co. LTD. | 2017-12-22 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers (NCT03364985) | Daewoong Pharmaceutical Co. LTD. | 2017-12-03 |
| DWP450 Treatment in Subjects With Benign Masseteric Hypertrophy (NCT03369990) | Daewoong Pharmaceutical Co. LTD. | 2017-12-01 |
| Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat (NCT03224117) | Daewoong Pharmaceutical Co. LTD. | 2017-10-26 |
| A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions (NCT03512821) | Daewoong Pharmaceutical Co. LTD. | 2017-10-01 |